Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.83%
Stock 71.26%
Bond 26.80%
Convertible 0.00%
Preferred 0.00%
Other 1.11%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 94.20%    % Emerging Markets: 4.51%    % Unidentified Markets: 1.29%

Americas 81.68%
78.64%
Canada 30.64%
United States 48.00%
3.04%
Brazil 3.04%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 9.30%
United Kingdom 2.93%
6.38%
Denmark 0.74%
France 0.13%
Ireland 0.02%
Netherlands 4.64%
Switzerland 0.85%
0.00%
0.00%
Greater Asia 7.73%
Japan 0.01%
0.00%
6.38%
Singapore 2.96%
South Korea 0.00%
Taiwan 3.41%
1.34%
China 1.34%
Unidentified Region 1.29%

Bond Credit Quality Exposure

AAA 18.57%
AA 13.18%
A 20.80%
BBB 37.23%
BB 2.16%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.88%
Not Available 7.18%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
15.49%
Materials
0.00%
Consumer Discretionary
6.46%
Financials
9.03%
Real Estate
0.00%
Sensitive
48.46%
Communication Services
1.35%
Energy
0.00%
Industrials
2.98%
Information Technology
44.13%
Defensive
7.73%
Consumer Staples
0.00%
Health Care
7.73%
Utilities
0.00%
Not Classified
28.33%
Non Classified Equity
0.00%
Not Classified - Non Equity
28.33%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 11.00%
Corporate 57.32%
Securitized 0.77%
Municipal 20.86%
Other 10.05%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.08%
Less than 1 Year
1.08%
Intermediate
58.26%
1 to 3 Years
9.00%
3 to 5 Years
15.82%
5 to 10 Years
33.44%
Long Term
38.96%
10 to 20 Years
5.61%
20 to 30 Years
20.34%
Over 30 Years
13.01%
Other
1.69%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial